aylmer Tag

0

WeedMD and Blockstrain Pilot a Proprietary Genome Tracking Program to Protect Cannabis Genetics & Intellectual Property

WeedMD Launches Blockstrain’s Revolutionary ‘Genome-to-Sale’ Software Toronto, Canada, October 24, 2018 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, and Blockstrain Technology Corp. (TSXV:DNAX.V) (OTC:DNAXF) (“Blockstrain”) are pleased to announce that they have kicked off the...

0

WeedMD Partners with Leading Quebec Product Formulation Laboratory to Spearhead Cannabis Product Development

Appoints Dr. Domenico Fuoco as Chief Innovation Officer Toronto, Canada, October 23, 2018 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has signed a pivotal agreement with Montreal-based Smart Medicines...

0

WeedMD Boosts Leadership Team with Key Appointments in Production, Sales, Marketing, Communications & HR

Newly-appointed executive team looks to expand robust seed-to-sale cannabis portfolio and amplify WeedMD’s brand recognition on a national and global level Toronto, Canada, October 15, 2018 – WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical-grade cannabis, is pleased...

0

Why R&D is Critical to the Future of the Cannabis Industry

Throughout Canada, the United States and internationally, therapeutic use of cannabis is increasing among patients supported by a growing consensus of medical professionals. Since doctors are generally trained to practice evidence-based medicine, the amount of research and development going into collecting clinical data and the...



Thanks for stopping by. Please note we have changed our corporate name to Entourage Health Corp. and can be now found at our new home:

EntourageHealthCorp.com


Come over and experience the Entourage!